Anzeige
Mehr »
Login
Dienstag, 01.04.2025 Börsentäglich über 12.000 News von 695 internationalen Medien
Kurs-Explosion voraus?: Diese kaum bekannte Aktie bohrt jetzt im Hotspot - und du erfährst es als Erster!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DMBV | ISIN: DK0061804770 | Ticker-Symbol: LDBA
Tradegate
01.04.25
17:35 Uhr
4,520 Euro
-0,164
-3,50 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
H LUNDBECK A/S B Chart 1 Jahr
5-Tage-Chart
H LUNDBECK A/S B 5-Tage-Chart
RealtimeGeldBriefZeit
4,4804,51421:55
4,4804,51421:55

Aktuelle News zur H LUNDBECK Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
17:21Lundbeck ends subcutaneous migraine cohort after futility review, pivots to IV formulation2
MoH. Lundbeck A/S: Following a planned interim analysis in the PROCEED trial Lundbeck expands the dose finding to intravenous administration of Lu AG09222 in migraine prevention153PROCEED is an adaptive Phase IIb trial with Lu AG09222, an investigational mAb intended to block signaling by pituitary adenylate cyclase-activating polypeptide (PACAP), a neuropeptide that...
► Artikel lesen
DoDividendenbekanntmachungen (27.03.2025)8.067 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  ABERDEEN GROUP PLC  GB00BF8Q6K64  0,073 GBP  0,0875 EUR  AFRICA OIL CORP  CA00829Q1019  0,0371 USD  0,0345 EUR  AGL ENERGY LIMITED  AU000000AGL7  0...
► Artikel lesen
MiH. Lundbeck A/S: Lundbeck held its Annual General Meeting on 26 March 2025 at the company's registered office321VALBY, Denmark, March 26, 2025 /PRNewswire/ -- H. Lundbeck A/S (Lundbeck) announced today that the report by the Board of Directors was adopted and the annual report was approved at the annual...
► Artikel lesen
25.03.Carl Zeiss Meditec, Lundbeck: Dividenden im global market - Ex-Tag 27.03.202547
14.03.EC approves Otsuka and Lundbeck's Rxulti for schizophrenia3
H LUNDBECK Aktie jetzt für 0€ handeln
13.03.H. Lundbeck A/S: Rxulti (brexpiprazole) approved in the European Union for the treatment of schizophrenia in adolescents aged 13 years and older315Brexpiprazole's indication for the treatment of schizophrenia in adults is extended to include adolescents aged 13 years and older1Approval follows a positive Committee for Medicinal Products...
► Artikel lesen
13.03.H. LUNDBECK A/S: Rxulti[®] (brexpiprazole) approved in the European Union for the treatment of schizophrenia in adolescents aged 13 years and older3
11.03.Lundbeck's amlenetug gains orphan drug status in Japan for MSA1
10.03.H. Lundbeck A/S: Lundbeck's potential treatment for Multiple System Atrophy granted Orphan Drug Designation in Japan262VALBY, Denmark, March 10, 2025 /PRNewswire/ -- The Ministry of Health, Labor, and Welfare (MHLW) in Japan has granted Orphan Drug Designation (ODD) to Lundbeck's investigational drug, amlenetug...
► Artikel lesen
25.02.H. Lundbeck A/S: To the shareholders of H. Lundbeck A/S146Notice of Annual General Meeting Notice is hereby given of the annual general meeting of H. Lundbeck A/S to be held on: Wednesday, 26 March 2025 at 10:00 am CET The annual general meeting will be...
► Artikel lesen
21.02.H. LUNDBECK A/S: Transactions with shares and linked securities in Lundbeck made by executives and their closely associated parties5
12.02.Lundbeck gains FDA fast track designation for MSA therapy amlenetug4
12.02.Lundbeck's Potential Treatment for Multiple System Atrophy Granted Fast Track Designation2
12.02.H. Lundbeck A/S: Lundbeck's potential treatment amlenetug for Multiple System Atrophy receives Fast Track Designation from the FDA379The FDA has granted Fast Track Designation to Lundbeck's investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MSA)....
► Artikel lesen
05.02.H. LUNDBECK A/S: Transactions with shares and linked securities in Lundbeck made by executives and their closely associated parties4
05.02.Lundbeck-Aktien fallen nach Umsatzverfehlung im vierten Quartal18
05.02.Lundbeck stock falls after Q4 revenue miss4
05.02.H. Lundbeck A/S: Lundbeck reached record revenue of DKK 22 billion in 2024 with accelerated growth for strategic brands (+21% CER)162Key highlights Lundbeck's total revenue grew by +14% CER[1] (+11% DKK) to DKK 22,004 million in 2024, with all regions contributing to growth United States: DKK 11,325 million (+16% CER; +15% DKK) Europe:...
► Artikel lesen
04.02.H. LUNDBECK A/S: Lundbeck announces changes to the Board of Directors1
Seite:  Weiter >>
57 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1